(Adnkronos) – “Three drugs, two bronchodilators and an inhaled steroid in a single device, reduce the risk of exacerbations in subjects with chronic obstructive pulmonary disease”. This was stated by Alberto Papi, professor of respiratory diseases at the University of Ferrara, among the scientific leaders of the conference organized in Rome by GSK Italia “Lung League. The winning team, from prevention to treatment”, the two-day event that brought together 200 Italian pulmonologists to take stock of the new therapies available for respiratory diseases.
#COPD #Papi #Unife #Triple #therapy #prolongs #survival
COPD, Papi (Unife): “Triple therapy prolongs survival”
